1 or 2 concurrent maintenance antiepileptic require at least 6 month since corticotropin at least 60 day since acetazolamide or zonisamide at least 60 day since investigational drug or device no ketogenic diet patient characteristic hematopoietic no hematological abnormality within 2 year hepatic no hepatic disease within 2 year renal no nephrolithiasis no other renal disease within 2 year cardiovascular no clinically significant electrocardiographic abnormality no cardiovascular disease within 2 year pulmonary no respiratory disease within 2 year other weight at least 25 lb 11.5 kg no medical disease within 2 year e.g rheumatic fever gastrointestinal abnormality malignancy no psychiatric or mood disorder inconsistent with lennox-gastaut within 6 month require any of the following electroconvulsive therapy antidepressant anxiolytic antipsychotic lithium carbonate no history of alcohol or drug abuse no history of poor compliance on past antiepileptic therapy able to take medication and maintain seizure calendar assistance allow adequate parental supervision 1 parent/guardian with adequate english fluency if english not patient's primary language the follow require of fertile woman negative serum-beta pregnancy test immediately prior to entry normal menstrual flow for 3 month prior to entry medically acceptable form of contraception during study 